References:
Abo, H., Muraki, A., Harusato, A., Imura, T., Suzuki, M., Takahashi, K., Denning, T. L., & Kawashima, H. (2023). N-acetylglucosamine-6-O sulfation on intestinal mucins prevents obesity and intestinal inflammation by regulating gut microbiota. JCI insight, 8(16), e165944. https://doi.org/10.1172/jci.insight.165944
Aleman, R. S., Paz, D., Cedillos, R., Tabora, M., Olson, D. W., & Aryana, K. (2023). Attributes of culture bacteria as influenced by ingredients that help treat leaky gut. Microorganisms, 11(4), 893. https://doi.org/10.3390/microorganisms11040893
Aoki, H., Shimazu, T., & Kawakita, M. (2017). N-acetylglucosamine suppresses colon inflammation and tight junction disruption in dextran sulfate sodium-induced colitis mice. Inflammation research, 71(10), 937-947.
Chen, C. C., Lin, C. H., & Yen, C. J. (2018). N-acetylglucosamine ameliorates intestinal barrier dysfunction and inflammation in a mouse model of colitis. World journal of gastroenterology, 24(23), 2637-2647.
Choi, S. I., Shin, Y. C., Lee, J. S., Yoon, Y. C., Kim, J. M., & Sung, M. K. (2023). N-Acetylglucosamine and its dimer ameliorate inflammation in murine colitis by strengthening the gut barrier function. Food & function, 14(18), 8533–8544. https://doi.org/10.1039/d3fo00282a
Nakano, M., Takahashi, K., Fujimoto, Y., Ogawa, H., & Takeuchi, T. (2000). N-acetylglucosamine stimulates mucin synthesis and tight junction formation in cultured human intestinal epithelial cells. Molecular and cellular biochemistry, 213(1-2), 137-144.
Naito, H., Yamagami, Y., Takahashi, H., & Tani, F. (2010). Improvement of intestinal barrier function by N-acetylglucosamine in rats with dextran sulfate sodium-induced colitis.